Decline in forced vital capacity (FVC) in subjects with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) compared with healthy references

被引：0
|
作者：
Valenzuela, Claudia [1 ]
Bonella, Francesco [2 ]
Moor, Catharina C. [3 ]
Weimann, Gerrit [4 ]
Miede, Corinna [5 ]
Stowasser, Susanne [4 ]
Maher, Toby M. [6 ,7 ]
机构：
[1] Univ Autonoma Madrid, Hosp Univ La Princesa, Pulmonol Dept, Madrid, Spain
[2] Univ Hosp Essen, Ctr Interstitial & Rare Lung Dis, Pneumol Dept, Ruhrlandklin, Essen, Germany
[3] Erasmus MC, Dept Pulm Dis, Rotterdam, Netherlands
[4] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[5] Mainanalyt GmbH, Sulzbach, Germany
[6] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[7] Imperial Coll London, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA673
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis
    Maher, Toby M.
    Stowasser, Susanne
    Voss, Florian
    Bendstrup, Elisabeth
    Kreuter, Michael
    Martinez, Fernando J.
    Sime, Patricia J.
    Stock, Christian
    RESPIROLOGY, 2023, 28 (12) : 1147 - 1153
  • [22] Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis
    Behr, J.
    Bonella, F.
    Bonnet, R.
    Glaeser, S.
    Grohe, C.
    Guenther, A.
    Koschel, D.
    Kreuter, M.
    Kirsten, D.
    Kroegel, C.
    Markart, P.
    Mueller-Quernheim, J.
    Neurohr, C.
    Pfeifer, M.
    Prasse, A.
    Schoenfeld, N.
    Schreiber, J.
    Wirtz, H.
    Witt, C.
    Costabel, U.
    PNEUMOLOGIE, 2015, 69 (08): : 455 - 458
  • [23] Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
    Bermudo, Guadalupe
    Suarez-Cuartin, Guillermo
    Rivera-Ortega, Pilar
    Rodriguez-Portal, Jose Antonio
    Sauleda, Jaume
    Nunez, Belen
    Castillo, Diego
    Aburto, Myriam
    Portillo, Karina
    Balcells, Eva
    Badenes-Bonet, Diana
    Valenzuela, Claudia
    Fernandez-Fabrellas, Estrella
    Gonzalez-Budino, Teresa
    Cano, Esteban
    Acosta, Orlando
    Leiro-Fernandez, Virginia
    Romero, Ana
    Planas-Cerezales, Lurdes
    Villar, Ana
    Moreno, Amalia
    Laporta, Rosalia
    Vicens-Zygmunt, Vanesa
    Shull, Jessica
    Franquet, Tomas
    Luburich, Patricio
    Molina-Molina, Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (02): : 135 - 141
  • [24] The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis
    Assayag, D.
    Vittinghoff, E.
    Ryerson, C. J.
    Cocconcelli, E.
    Tonelli, R.
    Elicker, B.
    Golden, J.
    Jones, K. D.
    King, T. E.
    Koth, L. L.
    Lee, J. S.
    Ley, B.
    Wolters, P. J.
    Collard, H. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [25] Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis
    Pesonen, Ida
    Gao, Jing
    Kalafatis, Dimitrios
    Carlson, Lisa
    Myllarniemi, Marjukka
    Ferrara, Giovanni
    Skold, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [26] Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
    Aono, Yuya
    Nakamura, Yutaro
    Kono, Masato
    Nakamura, Hidenori
    Yokomura, Koshi
    Imokawa, Shiro
    Toyoshima, Mikio
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Suda, Takafumi
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [27] Effect Of Continued Treatment With Pirfenidone Following A Clinically Meaningful Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Nathan, S. D.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Du Bois, R. M.
    Fagan, E. A.
    Glaspole, I.
    Glassberg, M. K.
    King, T. E.
    Lancaster, L.
    Lederer, D. J.
    Lin, Z.
    Pereira, C. A.
    Swigris, J. J.
    Valeyre, D.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [28] Effect Of Continued Treatment With Pirfenidone Following A ≥10% Relative Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Nathan, S. D.
    Albera, C.
    Costabel, U.
    Glaspole, I.
    Glassberg, M.
    Lancaster, L.
    Lederer, D. J.
    Pereira, C. A.
    Swigris, J.
    Day, B. -M.
    Chou, W.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A CLINICALLY MEANINGFUL DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Noble, P. W.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Lin, Z.
    Pereira, C. A.
    Swigris, J. J.
    Valeyre, D.
    Nathan, S. D.
    THORAX, 2015, 70 : A62 - A63
  • [30] 6 Minute Walk Distance (6MWD) and Forced Vital Capacity (FVC) in Patients with Idiopathic Pulmonary Fibrosis (IPF): Similar Pattern of Pirfenidone Response
    Valeyre, D.
    Albera, C.
    du Bois, R. M.
    Bradford, W. Z.
    Costabel, U.
    King, T. E., Jr.
    Noble, P. W.
    Szwarcberg, J.
    Sahn, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
12345